摘要
目的:观察平喘糖浆对支气管哮喘患者的治疗效果及其对哮喘患者外周血白细胞介素(IL-5)、嗜酸性粒细胞阳离子蛋白(ECP)、嗜酸性粒细胞(EOS)的影响。方法:将436名住院病人随机分成实验组(平喘糖浆组)和对照组(氨茶碱组),观察两组疗效以及IL-5、ECP、EQC的变化。结果:经4周治疗后,平喘糖浆能有效控制哮喘患者症状,有效率达到96.4%。显著高于氨茶碱对照组的78.31%(P<0.01),并且明显改善肺功能(P<0.01)。平喘糖浆能使外周血IL-5、ECP、EOS显著下降(P<0.01),其中IL-5、ECP下降幅度大于对照组(P<0.01)。结论:平喘糖浆对支气管哮喘患者可显著改善肺功能,有良好的临床疗效。
Objective:To observe the effect of relieving asthma syrup in patients with bronchial asthma,and the effec to leucocyte interleukin (IL-5),eosinophil cationic protein (ECP),eosinophil (EOS)in peripheral blood.Method:from 436 hospital patients were randomly divided into two groups the experimental groups(relieving asthma syrup groups)and the control groups (aminophylline groups),therapeutic effect of two groups were observed.Result:after 4 weeks treatment,relieving asthma syrup groups could control the symptom of asthma patients effectively.the effective power of achieved in 96.4% was higher than that of Aminophylline groups in 78.31%(p〈0.01).and improve the lung function obviously (p〈 0.01).relieving asthma syrup can descend IL-5,ECP,EOS in peripheral blood significantly(P〈0.01).the extent of descent of IL-5, ECP was larger than that of the control groups(P〈0.01).Conclusion: relieving asthma syrup colud improve the lung function obviously and have favourable clinical curative effect.
出处
《内蒙古中医药》
2006年第4期63-64,共2页
Inner Mongolia Journal of Traditional Chinese Medicine